These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
||
|
x
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the fiscal year ended October 31, 2015
|
|
or
|
||
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
For the transition period from to
|
|
Delaware
|
|
46-4254555
|
|
State or other jurisdiction of
Incorporation or organization
|
|
I.R.S. Employer
Identification No.
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Stock
par value $0.01 per share
|
|
New York Stock Exchange, Inc.
|
|
Large accelerated filer
T
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
Document Description
|
|
10-K Part
|
|
Portions of the Proxy Statement for the Annual Meeting of Stockholders (the "Proxy Statement") to be held on March 17, 2016 and to be filed pursuant to Regulation 14A within 120 days after registrant's fiscal year ended October 31, 2015 are incorporated by reference into Part III of this Report.
|
|
III
|
|
|
|
Page
|
|
|
||
|
|
||
|
|
||
|
|
||
|
•
|
Invest in new wireless communication measurement solutions.
We are investing in the development of new wireless communications test solutions to satisfy the market which is being driven by the explosive growth in mobile data and evolving wireless standards. The acquisition of Anite strengthens our wireless software design and test portfolio and its Network Test business expands our served addressable market.
|
|
•
|
Invest in modular solutions.
The market for modular solutions is expected to grow faster than the overall electronic measurement market. We are investing to leverage our strength in feature-rich instrumentation into a portfolio of modular measurement solutions.
|
|
•
|
Enhance and expand software solutions.
An increasing percentage of measurement science and functionality is delivered through software solutions. Our portfolio of software solutions and software productivity tools is extensive and represents a significant corporate asset. We will continue to invest in software development to capitalize on its growth potential.
|
|
•
|
Grow the services business.
Services is a new growth initiative with significant potential. Our focus on growing services through multi-vendor calibration and asset management builds upon a strong foundation of repair and calibration services and refurbished used equipment sales.
|
|
•
|
reduced demand for our products, delays in the shipment of orders or increases in order cancellations;
|
|
•
|
increased risk of excess and obsolete inventories;
|
|
•
|
increased price pressure for our products and services; and
|
|
•
|
greater risk of impairment to the value, and a detriment to the liquidity, of our future investment portfolio.
|
|
•
|
properly identify customer needs;
|
|
•
|
innovate and develop new technologies, services and applications;
|
|
•
|
successfully commercialize new technologies in a timely manner;
|
|
•
|
manufacture and deliver our products in sufficient volumes and on time;
|
|
•
|
differentiate our offerings from our competitors' offerings;
|
|
•
|
price our products competitively;
|
|
•
|
anticipate our competitors' development of new products, services or technological innovations; and control product quality in our manufacturing process.
|
|
•
|
interruption to transportation flows for delivery of parts to us and finished goods to our customers;
|
|
•
|
changes in foreign currency exchange rates;
|
|
•
|
changes in a specific country's or region's political, economic or other conditions;
|
|
•
|
trade protection measures, sanctions, and import or export licensing requirements or restrictions;
|
|
•
|
negative consequences from changes in tax laws;
|
|
•
|
difficulty in staffing and managing widespread operations;
|
|
•
|
differing labor regulations;
|
|
•
|
differing protection of intellectual property;
|
|
•
|
unexpected changes in regulatory requirements; and
|
|
•
|
volatile political environments or geopolitical turmoil, including regional conflicts, terrorism, and war.
|
|
•
|
the retention of key employees and/or customers;
|
|
•
|
the management of facilities and employees in different geographic areas; and
|
|
•
|
the compatibility of our infrastructure, policies and organizations with those of the acquired company.
|
|
•
|
requiring a portion of our cash flow from operations to make interest payments on this debt;
|
|
•
|
increasing our vulnerability to general adverse economic and industry conditions;
|
|
•
|
reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business; and
|
|
•
|
limiting our flexibility in planning for, or reacting to, changes in our business and the industry.
|
|
•
|
prior to the separation, our business was operated by Agilent as part of its broader corporate organization, rather than as an independent company. Agilent or one of its affiliates performed various corporate functions for us such as legal, treasury, accounting, auditing, human resources, corporate affairs and finance. Our historical financial results reflect allocations of corporate expenses from Agilent for such functions and are likely to be less than the expenses we would have incurred had we operated as a separate publicly-traded company. Following the separation, we are responsible for the cost related to such functions previously performed by Agilent;
|
|
•
|
generally, our working capital requirements and capital for our general corporate purposes, including acquisitions and capital expenditures, have historically been satisfied as part of the corporate-wide cash management policies of Agilent. Following the separation, we may need to obtain additional financing from banks, through public offerings or private placements of debt or equity securities, strategic relationships or other arrangements; and
|
|
•
|
our historical financial information does not reflect the debt or the associated interest expense that we have incurred as part of the separation and distribution.
|
|
•
|
actual or anticipated fluctuations in our operating results due to factors related to our business;
|
|
•
|
success or failure of our business strategy;
|
|
•
|
our quarterly or annual earnings, or those of other companies in our industry;
|
|
•
|
our ability to obtain third-party financing as needed;
|
|
•
|
announcements by us or our competitors of significant acquisitions or dispositions;
|
|
•
|
changes in accounting standards, policies, guidance, interpretations or principles;
|
|
•
|
the failure of securities analysts to cover our common stock;
|
|
•
|
changes in earnings estimates by securities analysts or our ability to meet those estimates;
|
|
•
|
the operating and share price performance of other comparable companies;
|
|
•
|
investor perception of our company;
|
|
•
|
natural or other disasters that investors believe may affect us;
|
|
•
|
overall market fluctuations;
|
|
•
|
results from any material litigation or government investigations;
|
|
•
|
changes in laws or regulations affecting our business; and
|
|
•
|
general economic conditions and other external factors.
|
|
•
|
the inability of our shareholders to call a special meeting;
|
|
•
|
the inability of our shareholders to act without a meeting of shareholders;
|
|
•
|
rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings;
|
|
•
|
the right of our board to issue preferred stock without shareholder approval;
|
|
•
|
the division of our board of directors into three classes of directors, with each class serving a staggered three-year term, and this classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult;
|
|
•
|
a provision that shareholders may only remove directors with cause;
|
|
•
|
the ability of our directors, and not shareholders, to fill vacancies on our board of directors; and
|
|
•
|
the requirement that the affirmative vote of shareholders holding at least 80% of our voting stock is required to amend certain provisions in our amended and restated certificate of incorporation (relating to the number, term and removal of our directors, the filling of our board vacancies, the advance notice to be given for nominations for elections of directors, the calling of special meetings of shareholders, shareholder action by written consent, the ability of the board of directors to amend the bylaws, elimination of liability of directors to the extent permitted by Delaware law, exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders and amendments of the certificate of incorporation) and certain provisions in our amended and restated bylaws (relating to the calling of special meetings of shareholders, the business that may be conducted or considered at annual or special meetings, the advance notice of shareholder business and nominations, shareholder action by written consent, the number, tenure, qualifications and removal of our directors, the filling of our board vacancies, director and officer indemnification and amendments of the bylaws).
|
|
Fiscal 2015
|
High
|
Low
|
Dividends
|
||||
|
First Quarter (ended January 31, 2015)
|
$
|
36.33
|
|
$
|
28.56
|
|
—
|
|
Second Quarter (ended April 30, 2015)
|
$
|
38.99
|
|
$
|
33.37
|
|
—
|
|
Third Quarter (ended July 31, 2015)
|
$
|
36.31
|
|
$
|
29.51
|
|
—
|
|
Fourth Quarter (ended October 31, 2015)
|
$
|
34.13
|
|
$
|
29.28
|
|
—
|
|
|
Years Ended October 31,
|
||||||||||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
||||||||||
|
|
(in millions, except per share data)
|
||||||||||||||||||
|
Combined and Consolidated Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net revenue
|
$
|
2,856
|
|
|
$
|
2,933
|
|
|
$
|
2,888
|
|
|
$
|
3,315
|
|
|
$
|
3,316
|
|
|
Income before taxes
|
$
|
388
|
|
|
$
|
475
|
|
|
$
|
501
|
|
|
$
|
746
|
|
|
$
|
749
|
|
|
Net income
|
$
|
513
|
|
|
$
|
392
|
|
|
$
|
457
|
|
|
$
|
841
|
|
|
$
|
787
|
|
|
Net income per share
(a)
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
$
|
3.04
|
|
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
$
|
5.04
|
|
|
$
|
4.71
|
|
|
Diluted
|
$
|
3.00
|
|
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
$
|
5.04
|
|
|
$
|
4.71
|
|
|
Weighted average shares used in computing net income per share
(a)
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
169
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|||||
|
Diluted
|
171
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
|||||
|
|
October 31,
|
||||||||||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
||||||||||
|
|
(in millions)
|
||||||||||||||||||
|
Combined and Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents and short-term investments
|
$
|
483
|
|
|
$
|
810
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Working capital
|
$
|
893
|
|
|
$
|
1,081
|
|
|
$
|
412
|
|
|
$
|
398
|
|
|
$
|
272
|
|
|
Total assets
|
$
|
3,508
|
|
|
$
|
3,050
|
|
|
$
|
2,028
|
|
|
$
|
2,133
|
|
|
$
|
1,908
|
|
|
Long-term debt
|
$
|
1,099
|
|
|
$
|
1,099
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Stockholders'/Invested equity
|
$
|
1,302
|
|
|
$
|
769
|
|
|
$
|
1,245
|
|
|
$
|
1,305
|
|
|
$
|
996
|
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Orders
|
$
|
2,853
|
|
|
$
|
2,963
|
|
|
$
|
2,866
|
|
|
(4)%
|
|
3%
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
||||||
|
Products
|
$
|
2,408
|
|
|
$
|
2,479
|
|
|
$
|
2,434
|
|
|
(3)%
|
|
2%
|
|
Services and other
|
448
|
|
|
454
|
|
|
454
|
|
|
(1)%
|
|
—%
|
|||
|
Total net revenue
|
$
|
2,856
|
|
|
$
|
2,933
|
|
|
$
|
2,888
|
|
|
(3)%
|
|
2%
|
|
|
Years Ended October 31,
|
|
2015 over 2014
Ppts Change |
|
2014 over 2013
Ppts Change |
|||||||
|
|
2015
|
|
2014
|
|
2013
|
|
||||||
|
% of total net revenue:
|
|
|
|
|
|
|
|
|
|
|||
|
Products
|
84
|
%
|
|
85
|
%
|
|
84
|
%
|
|
(1) ppt
|
|
1 ppt
|
|
Services and other
|
16
|
%
|
|
15
|
%
|
|
16
|
%
|
|
1 ppt
|
|
(1) ppt
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
|
Year over Year % Change
|
||||||||||
|
|
2015 over 2014
|
|
2014 over 2013
|
||||||||
|
Geographic Region
|
actual
|
|
currency adjusted
|
|
actual
|
|
currency adjusted
|
||||
|
Americas
|
—
|
%
|
|
1
|
%
|
|
3
|
%
|
|
3
|
%
|
|
Europe
|
(9
|
)%
|
|
(3
|
)%
|
|
6
|
%
|
|
5
|
%
|
|
Japan
|
(2
|
)%
|
|
10
|
%
|
|
(16
|
)%
|
|
(9
|
)%
|
|
Asia Pacific ex-Japan
|
(6
|
)%
|
|
(4
|
)%
|
|
11
|
%
|
|
11
|
%
|
|
Total orders
|
(4
|
)%
|
|
—
|
%
|
|
3
|
%
|
|
4
|
%
|
|
|
Year over Year % Change
|
||||||||||
|
|
2015 over 2014
|
|
2014 over 2013
|
||||||||
|
Geographic Region
|
actual
|
|
currency adjusted
|
|
actual
|
|
currency adjusted
|
||||
|
Americas
|
3
|
%
|
|
4
|
%
|
|
(3
|
)%
|
|
(2
|
)%
|
|
Europe
|
(8
|
)%
|
|
—
|
%
|
|
5
|
%
|
|
4
|
%
|
|
Japan
|
(6
|
)%
|
|
6
|
%
|
|
(9
|
)%
|
|
—
|
%
|
|
Asia Pacific ex-Japan
|
(5
|
)%
|
|
(4
|
)%
|
|
8
|
%
|
|
9
|
%
|
|
Total revenue
|
(3
|
)%
|
|
1
|
%
|
|
2
|
%
|
|
3
|
%
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
|||||||
|
|
2015
|
|
2014
|
|
2013
|
|
||||||
|
Gross margin on products
|
57.4
|
%
|
|
56.3
|
%
|
|
57.1
|
%
|
|
1 ppt
|
|
(1) ppt
|
|
Gross margin on services and other
|
45.6
|
%
|
|
49.4
|
%
|
|
51.3
|
%
|
|
(4) ppts
|
|
(2) ppts
|
|
Total gross margin
|
55.6
|
%
|
|
55.2
|
%
|
|
56.2
|
%
|
|
—
|
|
(1) ppt
|
|
Operating margin
|
15.1
|
%
|
|
16.0
|
%
|
|
17.2
|
%
|
|
(1) ppt
|
|
(1) ppt
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
387
|
|
|
$
|
361
|
|
|
$
|
375
|
|
|
7%
|
|
(4)%
|
|
Selling, general and administrative
|
$
|
787
|
|
|
$
|
790
|
|
|
$
|
752
|
|
|
—%
|
|
5%
|
|
Other operating expense (income), net
|
$
|
(18
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—%
|
|
—%
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Provision (benefit) for income taxes
|
$
|
(125
|
)
|
|
$
|
83
|
|
|
$
|
44
|
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Total net revenue
|
$
|
2,461
|
|
|
$
|
2,533
|
|
|
$
|
2,493
|
|
|
(3)%
|
|
2%
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
|||||||
|
|
2015
|
|
2014
|
|
2013
|
|
||||||
|
Total gross margin
|
59.1
|
%
|
|
57.6
|
%
|
|
58.6
|
%
|
|
2 ppts
|
|
(1) ppt
|
|
Operating margin
|
19.8
|
%
|
|
20.1
|
%
|
|
19.4
|
%
|
|
—
|
|
1 ppt
|
|
in millions
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
367
|
|
|
$
|
343
|
|
|
$
|
351
|
|
|
7%
|
|
(2)%
|
|
Selling, general and administrative
|
$
|
613
|
|
|
$
|
608
|
|
|
$
|
625
|
|
|
1%
|
|
(2)%
|
|
Other operating expense (income), net
|
$
|
(13
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—%
|
|
—%
|
|
Income from operations
|
$
|
487
|
|
|
$
|
508
|
|
|
$
|
484
|
|
|
(4)%
|
|
5%
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
|||||||||
|
|
(in millions)
|
|
|
|
|
||||||||||
|
Total net revenue
|
$
|
401
|
|
|
$
|
400
|
|
|
$
|
395
|
|
|
—%
|
|
1%
|
|
|
Years Ended October 31,
|
|
2015 over 2014
% Change |
|
2014 over 2013
% Change |
|||||||
|
|
2015
|
|
2014
|
|
2013
|
|
||||||
|
Total gross margin
|
42.9
|
%
|
|
46.3
|
%
|
|
48.4
|
%
|
|
(3) ppts
|
|
(2) ppts
|
|
Operating margin
|
17.9
|
%
|
|
23.1
|
%
|
|
24.9
|
%
|
|
(5) ppts
|
|
(2) ppts
|
|
in millions
|
|
|
|
|
|
|
|
|
|
||||||
|
Research and development
|
$
|
9
|
|
|
$
|
9
|
|
|
$
|
9
|
|
|
—%
|
|
—%
|
|
Selling, general and administrative
|
$
|
94
|
|
|
$
|
83
|
|
|
$
|
83
|
|
|
12%
|
|
—%
|
|
Other operating expense (income), net
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—%
|
|
—%
|
|
Income from operations
|
$
|
72
|
|
|
$
|
93
|
|
|
$
|
99
|
|
|
(22)%
|
|
(6)%
|
|
|
Total
|
|
Less than one
year
|
|
One to three years
|
|
Three to five years
|
|
More than five years
|
||||||||||
|
Long-term debt obligations
|
$
|
1,100
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
500
|
|
|
$
|
600
|
|
|
Interest payments on long-term debt
|
312
|
|
|
44
|
|
|
88
|
|
|
71
|
|
|
109
|
|
|||||
|
Operating leases
|
152
|
|
|
32
|
|
|
54
|
|
|
31
|
|
|
35
|
|
|||||
|
Commitments to contract manufacturers and suppliers
|
260
|
|
|
259
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|||||
|
Retirement plans
|
45
|
|
|
45
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Other purchase commitments
|
51
|
|
|
51
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
$
|
1,920
|
|
|
$
|
431
|
|
|
$
|
143
|
|
|
$
|
602
|
|
|
$
|
744
|
|
|
Index to Combined and Consolidated Financial Statements
|
|
Page
|
|
|
|
|
|
Combined and Consolidated Financial Statements:
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Net revenue:
|
|
|
|
|
|
||||||
|
Products
|
$
|
2,408
|
|
|
$
|
2,479
|
|
|
$
|
2,434
|
|
|
Services and other
|
448
|
|
|
454
|
|
|
454
|
|
|||
|
Total net revenue
|
2,856
|
|
|
2,933
|
|
|
2,888
|
|
|||
|
Costs and expenses:
|
|
|
|
|
|
||||||
|
Cost of products
|
1,025
|
|
|
1,083
|
|
|
1,044
|
|
|||
|
Cost of services and other
|
244
|
|
|
230
|
|
|
221
|
|
|||
|
Total costs
|
1,269
|
|
|
1,313
|
|
|
1,265
|
|
|||
|
Research and development
|
387
|
|
|
361
|
|
|
375
|
|
|||
|
Selling, general and administrative
|
787
|
|
|
790
|
|
|
752
|
|
|||
|
Other operating expense (income), net
|
(18
|
)
|
|
—
|
|
|
—
|
|
|||
|
Total costs and expenses
|
2,425
|
|
|
2,464
|
|
|
2,392
|
|
|||
|
Income from operations
|
431
|
|
|
469
|
|
|
496
|
|
|||
|
Interest income
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Interest expense
|
(46
|
)
|
|
(3
|
)
|
|
—
|
|
|||
|
Other income (expense), net
|
2
|
|
|
9
|
|
|
5
|
|
|||
|
Income before taxes
|
388
|
|
|
475
|
|
|
501
|
|
|||
|
Provision (benefit) for income taxes
|
(125
|
)
|
|
83
|
|
|
44
|
|
|||
|
Net income
|
$
|
513
|
|
|
$
|
392
|
|
|
$
|
457
|
|
|
|
|
|
|
|
|
||||||
|
Net income per share:
(a)
|
|
|
|
|
|
||||||
|
Basic
|
$
|
3.04
|
|
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
Diluted
|
$
|
3.00
|
|
|
$
|
2.35
|
|
|
$
|
2.74
|
|
|
|
|
|
|
|
|
||||||
|
Weighted average shares used in computing net income per share:
(a)
|
|
|
|
|
|
||||||
|
Basic
|
169
|
|
|
167
|
|
|
167
|
|
|||
|
Diluted
|
171
|
|
|
167
|
|
|
167
|
|
|||
|
|
Years Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Net income
|
$
|
513
|
|
|
$
|
392
|
|
|
$
|
457
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
||||||
|
Unrealized gain on investments, net of tax expense of $2, $4 and $3
|
5
|
|
|
8
|
|
|
5
|
|
|||
|
Unrealized gain (loss) on derivative instruments, net of tax benefit (expense) of $5, $(2) and zero
|
(10
|
)
|
|
3
|
|
|
—
|
|
|||
|
Amounts reclassified into earnings related to derivative instruments, net of tax benefit (expense) of zero
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Foreign currency translation, net of tax benefit (expense) of zero, $1 and $(6)
|
(54
|
)
|
|
(72
|
)
|
|
(75
|
)
|
|||
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
|
||||||
|
Change in actuarial net loss, net of tax benefit of $25, $13 and zero
|
(67
|
)
|
|
(38
|
)
|
|
—
|
|
|||
|
Change in net prior service credit, net of tax benefit of $11, $3 and zero
|
(18
|
)
|
|
(5
|
)
|
|
—
|
|
|||
|
Other comprehensive loss
|
(143
|
)
|
|
(104
|
)
|
|
(70
|
)
|
|||
|
Total comprehensive income
|
$
|
370
|
|
|
$
|
288
|
|
|
$
|
387
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
483
|
|
|
$
|
810
|
|
|
Accounts receivable, net
|
398
|
|
|
357
|
|
||
|
Receivable from Agilent
|
—
|
|
|
23
|
|
||
|
Inventory
|
487
|
|
|
498
|
|
||
|
Deferred tax assets
|
74
|
|
|
83
|
|
||
|
Other current assets
|
137
|
|
|
79
|
|
||
|
Total current assets
|
1,579
|
|
|
1,850
|
|
||
|
Property, plant and equipment, net
|
518
|
|
|
470
|
|
||
|
Goodwill
|
700
|
|
|
392
|
|
||
|
Other intangible assets, net
|
246
|
|
|
18
|
|
||
|
Long-term investments
|
70
|
|
|
63
|
|
||
|
Long-term deferred tax assets
|
295
|
|
|
163
|
|
||
|
Other assets
|
100
|
|
|
94
|
|
||
|
Total assets
|
$
|
3,508
|
|
|
$
|
3,050
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
209
|
|
|
$
|
173
|
|
|
Payable to Agilent
|
—
|
|
|
125
|
|
||
|
Employee compensation and benefits
|
168
|
|
|
167
|
|
||
|
Deferred revenue
|
175
|
|
|
175
|
|
||
|
Income and other taxes payable
|
50
|
|
|
72
|
|
||
|
Other accrued liabilities
|
84
|
|
|
57
|
|
||
|
Total current liabilities
|
686
|
|
|
769
|
|
||
|
Long-term deferred revenue
|
61
|
|
|
69
|
|
||
|
Long-term debt
|
1,099
|
|
|
1,099
|
|
||
|
Retirement and post-retirement benefits
|
280
|
|
|
213
|
|
||
|
Other long-term liabilities
|
80
|
|
|
131
|
|
||
|
Total liabilities
|
2,206
|
|
|
2,281
|
|
||
|
Commitments and contingencies (Note 18)
|
|
|
|
|
|
||
|
Total equity:
|
|
|
|
||||
|
Stockholders' equity:
|
|
|
|
||||
|
Preferred stock; $0.01 par value; 100 million shares authorized; none issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock; $0.01 par value; 1 billion shares authorized; 170 million shares issued and outstanding at October 31, 2015, and 167 million shares issued and outstanding at October 31, 2014
|
2
|
|
|
2
|
|
||
|
Additional paid-in-capital
|
1,165
|
|
|
1,002
|
|
||
|
Retained earnings
|
614
|
|
|
101
|
|
||
|
Accumulated other comprehensive loss
|
(479
|
)
|
|
(336
|
)
|
||
|
Total stockholders' equity
|
1,302
|
|
|
769
|
|
||
|
Total liabilities and equity
|
$
|
3,508
|
|
|
$
|
3,050
|
|
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
513
|
|
|
$
|
392
|
|
|
$
|
457
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
99
|
|
|
84
|
|
|
77
|
|
|||
|
Share-based compensation
|
55
|
|
|
43
|
|
|
41
|
|
|||
|
Excess tax benefit from share based plans
|
(4
|
)
|
|
(4
|
)
|
|
—
|
|
|||
|
Deferred taxes
|
(163
|
)
|
|
23
|
|
|
14
|
|
|||
|
Excess and obsolete inventory related charges
|
28
|
|
|
33
|
|
|
21
|
|
|||
|
Asset impairment charges
|
—
|
|
|
—
|
|
|
1
|
|
|||
|
Other non-cash expenses (income), net
|
14
|
|
|
(1
|
)
|
|
1
|
|
|||
|
Changes in assets and liabilities:
|
|
|
|
|
|
||||||
|
Accounts receivable, net
|
(20
|
)
|
|
(25
|
)
|
|
44
|
|
|||
|
Inventory
|
(25
|
)
|
|
(31
|
)
|
|
(53
|
)
|
|||
|
Accounts payable
|
18
|
|
|
32
|
|
|
(24
|
)
|
|||
|
Payment (to)/from Agilent, net
|
(28
|
)
|
|
23
|
|
|
—
|
|
|||
|
Employee compensation and benefits
|
6
|
|
|
30
|
|
|
—
|
|
|||
|
Income and other taxes payable
|
2
|
|
|
63
|
|
|
(2
|
)
|
|||
|
Retirement and post-retirement benefits
|
(38
|
)
|
|
(32
|
)
|
|
—
|
|
|||
|
Other assets and liabilities
|
(81
|
)
|
|
(67
|
)
|
|
(11
|
)
|
|||
|
Net cash provided by operating activities
|
376
|
|
|
563
|
|
|
566
|
|
|||
|
|
|
|
|
|
|
||||||
|
Cash flows from investing activities:
|
|
|
|
|
|
||||||
|
Purchases of property, plant and equipment
|
(92
|
)
|
|
(70
|
)
|
|
(69
|
)
|
|||
|
Proceeds from the sale of property, plant and equipment
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Acquisitions of businesses and intangible assets, net of cash acquired
|
(574
|
)
|
|
(11
|
)
|
|
(1
|
)
|
|||
|
Purchase of investments
|
(7
|
)
|
|
—
|
|
|
(15
|
)
|
|||
|
Proceeds from the sale of investments
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Change in restricted cash, cash equivalents and investments
|
—
|
|
|
(2
|
)
|
|
—
|
|
|||
|
Other
|
—
|
|
|
1
|
|
|
—
|
|
|||
|
Net cash used in investing activities
|
(671
|
)
|
|
(82
|
)
|
|
(85
|
)
|
|||
|
|
|
|
|
|
|
||||||
|
Cash flows from financing activities:
|
|
|
|
|
|
||||||
|
Issuance of common stock under employee stock plans
|
26
|
|
|
—
|
|
|
—
|
|
|||
|
Issuance of senior notes
|
—
|
|
|
1,099
|
|
|
—
|
|
|||
|
Debt issuance costs
|
—
|
|
|
(10
|
)
|
|
—
|
|
|||
|
Proceeds from short term borrowings
|
—
|
|
|
2
|
|
|
—
|
|
|||
|
Repayment of debts and credit facility
|
—
|
|
|
(37
|
)
|
|
—
|
|
|||
|
Excess tax benefit from share-based plans
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Return of capital to Agilent
|
(49
|
)
|
|
(940
|
)
|
|
—
|
|
|||
|
Net transfers from/(to) Agilent
|
—
|
|
|
217
|
|
|
(481
|
)
|
|||
|
Net cash provided by/(used in) financing activities
|
(19
|
)
|
|
335
|
|
|
(481
|
)
|
|||
|
Effect of exchange rate movements
|
(13
|
)
|
|
(6
|
)
|
|
—
|
|
|||
|
Net increase/(decrease) in cash and cash equivalents
|
(327
|
)
|
|
810
|
|
|
—
|
|
|||
|
Cash and cash equivalents at beginning of year
|
810
|
|
|
—
|
|
|
—
|
|
|||
|
Cash and cash equivalents at end of year
|
$
|
483
|
|
|
$
|
810
|
|
|
$
|
—
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
Number of Shares
|
|
Par Value
|
|
Additional Paid-in Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Income/(Loss)
|
Agilent Net Investment
|
|
Total Equity
|
||||||||||||||
|
Balance as of October 31, 2012
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
101
|
|
|
$
|
1,204
|
|
|
$
|
1,305
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
457
|
|
|
457
|
|
||||||
|
Other comprehensive loss, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(70
|
)
|
|
—
|
|
|
(70
|
)
|
||||||
|
Net transfers to Agilent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(447
|
)
|
|
(447
|
)
|
||||||
|
Balance as of October 31, 2013
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
31
|
|
|
$
|
1,214
|
|
|
$
|
1,245
|
|
|
Net income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Pre-capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
291
|
|
|
291
|
|
||||||
|
Post-capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
101
|
|
|
—
|
|
|
—
|
|
|
101
|
|
||||||
|
Other comprehensive loss, net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Pre-capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
||||||
|
Post-capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(96
|
)
|
|
—
|
|
|
(96
|
)
|
||||||
|
Net transfers to Agilent (pre-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(267
|
)
|
|
(267
|
)
|
||||||
|
Transfers due to Capitalization
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(263
|
)
|
|
780
|
|
|
517
|
|
||||||
|
Return of capital to Agilent (post-capitalization)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(900
|
)
|
|
(900
|
)
|
||||||
|
Excess cash paid or payable to Agilent
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(114
|
)
|
|
(114
|
)
|
||||||
|
Issuance of common stock and reclassification of parent company investment in connection with separation
|
167,483
|
|
|
2
|
|
|
1,002
|
|
|
—
|
|
|
—
|
|
|
(1,004
|
)
|
|
—
|
|
||||||
|
Balance as of October 31, 2014
|
167,483
|
|
|
$
|
2
|
|
|
$
|
1,002
|
|
|
$
|
101
|
|
|
$
|
(336
|
)
|
|
$
|
—
|
|
|
$
|
769
|
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
513
|
|
|
—
|
|
|
—
|
|
|
513
|
|
||||||
|
Other comprehensive loss, net of tax
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(143
|
)
|
|
—
|
|
|
(143
|
)
|
||||||
|
Share-based awards issued
|
2,108
|
|
|
—
|
|
|
18
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18
|
|
||||||
|
Share-based compensation
|
—
|
|
|
—
|
|
|
54
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
54
|
|
||||||
|
Tax benefits from share-based awards issued
|
—
|
|
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
||||||
|
Separation related tax and pension adjustments
|
—
|
|
|
—
|
|
|
62
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
62
|
|
||||||
|
Reduction in cash payable to Agilent
|
—
|
|
|
—
|
|
|
25
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
25
|
|
||||||
|
Balance as of October 31, 2015
|
169,591
|
|
|
$
|
2
|
|
|
$
|
1,165
|
|
|
$
|
614
|
|
|
$
|
(479
|
)
|
|
$
|
—
|
|
|
$
|
1,302
|
|
|
Cash and cash equivalents
|
$
|
43
|
|
|
Accounts receivable
|
32
|
|
|
|
Inventory
|
19
|
|
|
|
Deferred tax assets
|
1
|
|
|
|
Other current assets
|
10
|
|
|
|
Property, plant and equipment
|
34
|
|
|
|
Intangible assets
|
244
|
|
|
|
Goodwill
|
317
|
|
|
|
Long-term deferred tax assets
|
4
|
|
|
|
Total assets acquired
|
704
|
|
|
|
Accounts payable
|
(10
|
)
|
|
|
Employee compensation and benefits
|
(3
|
)
|
|
|
Deferred revenue
|
(17
|
)
|
|
|
Income and other taxes payable
|
(1
|
)
|
|
|
Other accrued liabilities
|
(20
|
)
|
|
|
Other long-term liabilities
|
(50
|
)
|
|
|
Net assets acquired
|
$
|
603
|
|
|
|
Estimated Fair Value
|
Estimated useful life
|
||
|
Developed product technology
|
$
|
182
|
|
6 years
|
|
Customer relationships
|
31
|
|
8 years
|
|
|
Tradenames and trademarks
|
19
|
|
10 years
|
|
|
Total intangible assets subject to amortization
|
232
|
|
|
|
|
In-process research and development
|
12
|
|
|
|
|
Total intangible assets
|
$
|
244
|
|
|
|
|
2015
|
|
2014
|
||||
|
Net revenue
|
$
|
2,998
|
|
|
$
|
3,096
|
|
|
Net income
|
$
|
510
|
|
|
$
|
422
|
|
|
Net income per share - Basic
|
$
|
3.02
|
|
|
$
|
2.53
|
|
|
Net income per share - Diluted
|
$
|
2.98
|
|
|
$
|
2.53
|
|
|
|
Years ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
Cost of products and services
|
$
|
—
|
|
|
$
|
96
|
|
|
$
|
93
|
|
|
Research and development
|
—
|
|
|
44
|
|
|
54
|
|
|||
|
Selling, general and administrative
|
—
|
|
|
273
|
|
|
257
|
|
|||
|
Other (income) expense
|
—
|
|
|
(4
|
)
|
|
(4
|
)
|
|||
|
Total allocated costs
|
$
|
—
|
|
|
$
|
409
|
|
|
$
|
400
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
Receivable from Agilent
|
$
|
—
|
|
|
$
|
23
|
|
|
Payable to Agilent
|
$
|
—
|
|
|
$
|
125
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Cost of products and services
|
$
|
12
|
|
|
$
|
11
|
|
|
$
|
9
|
|
|
Research and development
|
9
|
|
|
7
|
|
|
7
|
|
|||
|
Selling, general and administrative
|
34
|
|
|
26
|
|
|
27
|
|
|||
|
Total share-based compensation expense
|
$
|
55
|
|
|
$
|
44
|
|
|
$
|
43
|
|
|
|
Years Ended October 31,
|
||||
|
|
2015
|
|
2014
|
|
2013
|
|
Stock Option Plans:
|
|
|
|
|
|
|
Weighted average risk-free interest rate
|
1.60%
|
|
1.69%
|
|
0.86%
|
|
Dividend yield
|
0%
|
|
1%
|
|
1%
|
|
Weighted average volatility
|
31%
|
|
39%
|
|
39%
|
|
Expected life
|
4.9 years
|
|
5.8 years
|
|
5.8 years
|
|
LTP Program:
|
|
|
|
|
|
|
Volatility of Keysight shares (Agilent shares for FY13)
|
26%
|
|
—
|
|
37%
|
|
Volatility of selected peer-company shares
|
17%-67%
|
|
—
|
|
6%-64%
|
|
Price-wise correlation with selected peers
|
38%
|
|
—
|
|
49%
|
|
|
Options
Outstanding
|
|
Weighted
Average
Exercise Price
|
|||
|
|
(in thousands)
|
|
|
|||
|
Outstanding at October 31, 2014
|
2,202
|
|
|
$
|
36
|
|
|
Keysight converted at October 31, 2014
(a)
|
3,947
|
|
|
$
|
20
|
|
|
Granted
|
968
|
|
|
$
|
31
|
|
|
Exercised
|
(830
|
)
|
|
$
|
16
|
|
|
Forfeited and expired
|
(60
|
)
|
|
$
|
18
|
|
|
Outstanding at October 31, 2015
|
4,025
|
|
|
$
|
24
|
|
|
(a)
|
Awards outstanding/unvested held by Keysight employees on October 31, 2014 were converted into Keysight awards to maintain their pre-distribution intrinsic value based on Agilent’s closing stock price of
$55.28
on October 31, 2014. The adjusted number of awards were calculated using the post-spin Keysight stock price of
$30.80
, which is the volume-weighted average trading price of Keysight Shares over the first two trading sessions immediately after the Distribution Date, computed by dividing (i) the aggregate sales price of all shares sold over the NYSE during such two trading sessions, by (ii) the number of such sold shares.
|
|
|
Options canceled
|
|
Weighted Average Exercise Price
|
|||
|
|
(in thousands)
|
|
|
|||
|
Forfeited
|
16
|
|
|
$
|
27
|
|
|
Expired
|
44
|
|
|
$
|
15
|
|
|
Total options canceled during 2015
|
60
|
|
|
$
|
18
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
||||||||||||||||||||||
|
Range of
Exercise Prices
|
Number
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
Weighted
Average
Exercise
Price
|
|
Aggregate
Intrinsic
Value
|
|
Number
Exercisable
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
Weighted
Average
Exercise
Price
|
|
Aggregate
Intrinsic
Value
|
||||||||||
|
|
(in thousands)
|
|
(in years)
|
|
|
|
(in thousands)
|
|
(in thousands)
|
|
(in years)
|
|
|
|
(in thousands)
|
||||||||||
|
$0 - 25
|
2,314
|
|
|
4.2
|
|
$
|
19
|
|
|
$
|
32,648
|
|
|
1,714
|
|
|
3.4
|
|
$
|
19
|
|
|
$
|
24,928
|
|
|
$25.01 - 30
|
737
|
|
|
8.1
|
|
$
|
30
|
|
|
2,400
|
|
|
182
|
|
|
8.1
|
|
$
|
30
|
|
|
591
|
|
||
|
$30.01 - 40
|
974
|
|
|
9.0
|
|
$
|
31
|
|
|
2,020
|
|
|
3
|
|
|
8.4
|
|
$
|
31
|
|
|
5
|
|
||
|
|
4,025
|
|
|
6.1
|
|
$
|
24
|
|
|
$
|
37,068
|
|
|
1,899
|
|
|
3.8
|
|
$
|
20
|
|
|
$
|
25,524
|
|
|
|
Aggregate
Intrinsic Value
|
|
Weighted
Average
Exercise
Price
|
|
Per Share Value Using
Black-Scholes
Model
|
||||||
|
|
(in thousands)
|
|
|
|
|
||||||
|
Options exercised in fiscal 2013
|
$
|
26,808
|
|
|
$
|
28
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2013
|
|
|
|
|
|
|
$
|
12
|
|
||
|
Options exercised in fiscal 2014
|
$
|
39,886
|
|
|
$
|
30
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2014
|
|
|
|
|
|
|
$
|
19
|
|
||
|
Options exercised in fiscal 2015
|
$
|
15,160
|
|
|
$
|
16
|
|
|
|
|
|
|
Black-Scholes per share value of options granted during fiscal 2015
|
|
|
|
|
|
|
$
|
9
|
|
||
|
|
Shares
|
|
Weighted
Average
Grant Date Fair Value
|
|||
|
|
(in thousands)
|
|
|
|||
|
Non-vested at October 31, 2014
|
1,422
|
|
|
$
|
44
|
|
|
Keysight converted at October 31, 2014
(a)
|
2,552
|
|
|
$
|
25
|
|
|
Granted
|
1,725
|
|
|
$
|
33
|
|
|
Vested
|
(1,052
|
)
|
|
$
|
25
|
|
|
Forfeited
|
(39
|
)
|
|
$
|
29
|
|
|
Change in LTP Program shares vested in the year due to performance conditions
|
(66
|
)
|
|
$
|
28
|
|
|
Non-vested at October 31, 2015
|
3,120
|
|
|
$
|
29
|
|
|
(a)
|
Awards outstanding/unvested held by Keysight employees on October 31, 2014 were converted into Keysight awards to maintain their pre-distribution intrinsic value based on Agilent’s closing stock price of
$55.28
on October 31, 2014. The adjusted number of awards were calculated using the post-spin Keysight stock price of
$30.80
, which is the volume-weighted average trading price of Keysight Shares over the first two trading sessions immediately after the Distribution Date, computed by dividing (i) the aggregate sales price of all shares sold over the NYSE during such two trading sessions, by (ii) the number of such sold shares.
|
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
U.S. operations
|
$
|
(6
|
)
|
|
$
|
(18
|
)
|
|
$
|
14
|
|
|
Non-U.S. operations
|
394
|
|
|
493
|
|
|
487
|
|
|||
|
Total income before taxes
|
$
|
388
|
|
|
$
|
475
|
|
|
$
|
501
|
|
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
U.S. federal taxes:
|
|
|
|
|
|
||||||
|
Current
|
$
|
12
|
|
|
$
|
(11
|
)
|
|
$
|
10
|
|
|
Deferred
|
(7
|
)
|
|
25
|
|
|
12
|
|
|||
|
Non-U.S. taxes:
|
|
|
|
|
|
||||||
|
Current
|
24
|
|
|
62
|
|
|
16
|
|
|||
|
Deferred
|
(158
|
)
|
|
(4
|
)
|
|
3
|
|
|||
|
State taxes, net of federal benefit:
|
|
|
|
|
|
||||||
|
Current
|
1
|
|
|
9
|
|
|
4
|
|
|||
|
Deferred
|
3
|
|
|
2
|
|
|
(1
|
)
|
|||
|
Total provision (benefit) for income taxes
|
$
|
(125
|
)
|
|
$
|
83
|
|
|
$
|
44
|
|
|
|
October 31,
|
||||||||||||||
|
|
2015
|
|
2014
|
||||||||||||
|
|
Deferred
Tax Assets
|
|
Deferred Tax
Liabilities
|
|
Deferred
Tax Assets
|
|
Deferred Tax
Liabilities
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Inventory
|
$
|
12
|
|
|
$
|
(1
|
)
|
|
$
|
20
|
|
|
$
|
—
|
|
|
Intangibles
|
131
|
|
|
(15
|
)
|
|
35
|
|
|
(6
|
)
|
||||
|
Property, plant and equipment
|
25
|
|
|
(11
|
)
|
|
28
|
|
|
(10
|
)
|
||||
|
Warranty reserves
|
20
|
|
|
—
|
|
|
18
|
|
|
—
|
|
||||
|
Pension benefits
|
66
|
|
|
(18
|
)
|
|
61
|
|
|
(18
|
)
|
||||
|
Employee benefits, other than retirement
|
27
|
|
|
—
|
|
|
26
|
|
|
—
|
|
||||
|
Net operating loss, capital loss, and credit carryforwards
|
135
|
|
|
—
|
|
|
127
|
|
|
—
|
|
||||
|
State taxes
|
—
|
|
|
—
|
|
|
6
|
|
|
—
|
|
||||
|
Unremitted earnings of foreign subsidiaries
|
—
|
|
|
(33
|
)
|
|
—
|
|
|
(53
|
)
|
||||
|
Share-based compensation
|
23
|
|
|
—
|
|
|
15
|
|
|
—
|
|
||||
|
Deferred revenue
|
36
|
|
|
(3
|
)
|
|
42
|
|
|
(1
|
)
|
||||
|
Other
|
11
|
|
|
(7
|
)
|
|
3
|
|
|
(11
|
)
|
||||
|
Subtotal
|
486
|
|
|
(88
|
)
|
|
381
|
|
|
(99
|
)
|
||||
|
Tax valuation allowance
|
(46
|
)
|
|
—
|
|
|
(39
|
)
|
|
—
|
|
||||
|
Total deferred tax assets or deferred tax liabilities
|
$
|
440
|
|
|
$
|
(88
|
)
|
|
$
|
342
|
|
|
$
|
(99
|
)
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Current deferred tax assets
|
$
|
74
|
|
|
$
|
83
|
|
|
Long-term deferred tax assets
|
295
|
|
|
163
|
|
||
|
Current deferred tax liabilities (included within other accrued liabilities)
|
(2
|
)
|
|
(1
|
)
|
||
|
Long-term deferred tax liabilities (included within other long-term liabilities)
|
(15
|
)
|
|
(2
|
)
|
||
|
Total
|
$
|
352
|
|
|
$
|
243
|
|
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Profit before tax times statutory rate
|
$
|
136
|
|
|
$
|
166
|
|
|
$
|
175
|
|
|
State income taxes, net of federal benefit
|
3
|
|
|
6
|
|
|
2
|
|
|||
|
Non-U.S. income taxed at different rates
|
(107
|
)
|
|
(113
|
)
|
|
(147
|
)
|
|||
|
Singapore tax incentives through amortization
|
(219
|
)
|
|
—
|
|
|
—
|
|
|||
|
Retroactive Singapore tax rate incentive impact
|
(15
|
)
|
|
|
|
|
|||||
|
Repatriation of foreign earnings
|
—
|
|
|
62
|
|
|
8
|
|
|||
|
Foreign earnings not considered indefinitely reinvested
|
33
|
|
|
—
|
|
|
—
|
|
|||
|
Change in unrecognized tax benefits
|
33
|
|
|
(39
|
)
|
|
6
|
|
|||
|
Valuation allowances
|
—
|
|
|
(5
|
)
|
|
—
|
|
|||
|
Other, net
|
11
|
|
|
6
|
|
|
—
|
|
|||
|
Provision (benefit) for income taxes
|
$
|
(125
|
)
|
|
$
|
83
|
|
|
$
|
44
|
|
|
Effective tax rate
|
(32
|
)%
|
|
18
|
%
|
|
9
|
%
|
|||
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Current income tax liabilities (included within income and other taxes payable)
|
$
|
(3
|
)
|
|
$
|
(60
|
)
|
|
Long-term income tax liabilities (included within other long-term liabilities)
|
(14
|
)
|
|
(82
|
)
|
||
|
Total
|
$
|
(17
|
)
|
|
$
|
(142
|
)
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Balance, beginning of year
|
$
|
129
|
|
|
$
|
173
|
|
|
$
|
162
|
|
|
Reductions due to spin transaction
|
(113
|
)
|
|
—
|
|
|
—
|
|
|||
|
Additions due to acquisition
|
2
|
|
|
—
|
|
|
—
|
|
|||
|
Additions for tax positions related to the current year
|
34
|
|
|
10
|
|
|
9
|
|
|||
|
Additions for tax positions from prior years
|
2
|
|
|
9
|
|
|
5
|
|
|||
|
Reductions for tax positions from prior years
|
(4
|
)
|
|
(59
|
)
|
|
(2
|
)
|
|||
|
Settlements with taxing authorities
|
—
|
|
|
(1
|
)
|
|
—
|
|
|||
|
Statute of limitations expirations
|
—
|
|
|
(3
|
)
|
|
(1
|
)
|
|||
|
Balance, end of year
|
$
|
50
|
|
|
$
|
129
|
|
|
$
|
173
|
|
|
|
Year Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Numerator:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
513
|
|
|
$
|
392
|
|
|
$
|
457
|
|
|
Denominator:
|
|
|
|
|
|
||||||
|
Basic weighted-average shares(a)
|
169
|
|
|
167
|
|
|
167
|
|
|||
|
Potential common shares— stock options and other employee stock plans
|
2
|
|
|
—
|
|
|
—
|
|
|||
|
Diluted weighted-average shares(a)
|
171
|
|
|
167
|
|
|
167
|
|
|||
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Finished goods
|
$
|
235
|
|
|
$
|
219
|
|
|
Purchased parts and fabricated assemblies
|
252
|
|
|
279
|
|
||
|
Inventory
|
$
|
487
|
|
|
$
|
498
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Land
|
$
|
61
|
|
|
$
|
61
|
|
|
Buildings and leasehold improvements
|
653
|
|
|
627
|
|
||
|
Machinery and equipment
|
915
|
|
|
867
|
|
||
|
Total property, plant and equipment
|
1,629
|
|
|
1,555
|
|
||
|
Accumulated depreciation and amortization
|
(1,111
|
)
|
|
(1,085
|
)
|
||
|
Property, plant and equipment, net
|
$
|
518
|
|
|
$
|
470
|
|
|
|
Customer Support and Services
|
|
Measurement Solutions
|
|
Total
|
||||||
|
|
(in millions)
|
||||||||||
|
Goodwill as of October 31, 2013
|
$
|
54
|
|
|
$
|
365
|
|
|
$
|
419
|
|
|
Foreign currency translation impact
|
(4
|
)
|
|
(28
|
)
|
|
(32
|
)
|
|||
|
Goodwill arising from acquisitions and other adjustments
|
5
|
|
|
—
|
|
|
5
|
|
|||
|
Goodwill as of October 31, 2014
|
$
|
55
|
|
|
$
|
337
|
|
|
$
|
392
|
|
|
Foreign currency translation impact
|
(2
|
)
|
|
(17
|
)
|
|
(19
|
)
|
|||
|
Goodwill arising from acquisitions and other adjustments
|
10
|
|
|
317
|
|
|
327
|
|
|||
|
Goodwill as of October 31, 2015
|
$
|
63
|
|
|
$
|
637
|
|
|
$
|
700
|
|
|
|
Other Intangible Assets
|
||||||||||
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
and Impairments
|
|
Net Book
Value
|
||||||
|
|
(in millions)
|
||||||||||
|
As of October 31, 2014:
|
|
|
|
|
|
||||||
|
Developed technology
|
$
|
125
|
|
|
$
|
114
|
|
|
$
|
11
|
|
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
1
|
|
|
1
|
|
|
—
|
|
|||
|
Customer relationships
|
32
|
|
|
25
|
|
|
7
|
|
|||
|
Total amortizable intangible assets
|
$
|
162
|
|
|
$
|
144
|
|
|
$
|
18
|
|
|
In-Process R&D
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Total
|
$
|
162
|
|
|
$
|
144
|
|
|
$
|
18
|
|
|
As of October 31, 2015:
|
|
|
|
|
|
||||||
|
Developed technology
|
$
|
305
|
|
|
$
|
125
|
|
|
$
|
180
|
|
|
Backlog
|
4
|
|
|
4
|
|
|
—
|
|
|||
|
Trademark/Tradename
|
20
|
|
|
2
|
|
|
18
|
|
|||
|
Customer relationships
|
64
|
|
|
28
|
|
|
36
|
|
|||
|
Total amortizable intangible assets
|
$
|
393
|
|
|
$
|
159
|
|
|
$
|
234
|
|
|
In-Process R&D
|
12
|
|
|
—
|
|
|
12
|
|
|||
|
Total
|
$
|
405
|
|
|
$
|
159
|
|
|
$
|
246
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Long-Term
|
|
|
|
||||
|
Cost method investments
|
$
|
17
|
|
|
$
|
15
|
|
|
Trading securities
|
12
|
|
|
13
|
|
||
|
Available-for-sale investments
|
41
|
|
|
35
|
|
||
|
Total
|
$
|
70
|
|
|
$
|
63
|
|
|
|
October 31, 2015
|
|
October 31, 2014
|
||||||||||||||||||||||||||||
|
|
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair
Value
|
|
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair
Value
|
||||||||||||||||
|
|
(in millions)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Equity securities
|
$
|
15
|
|
|
$
|
26
|
|
|
$
|
—
|
|
|
$
|
41
|
|
|
$
|
15
|
|
|
$
|
20
|
|
|
$
|
—
|
|
|
$
|
35
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2015 Using |
||||||||||||
|
|
October 31,
2015 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents (money market funds)
|
$
|
295
|
|
|
$
|
295
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivative instruments (foreign exchange contracts)
|
1
|
|
|
—
|
|
|
1
|
|
|
—
|
|
||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
12
|
|
|
12
|
|
|
—
|
|
|
—
|
|
||||
|
Available-for-sale investments
|
41
|
|
|
41
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
349
|
|
|
$
|
348
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Derivative instruments (foreign exchange contracts)
|
$
|
10
|
|
|
$
|
—
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
12
|
|
|
—
|
|
|
12
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
22
|
|
|
$
|
—
|
|
|
$
|
22
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using |
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Cash equivalents (money market funds)
|
$
|
634
|
|
|
$
|
634
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivative instruments (foreign exchange contracts)
|
9
|
|
|
—
|
|
|
9
|
|
|
—
|
|
||||
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Trading securities
|
13
|
|
|
13
|
|
|
—
|
|
|
—
|
|
||||
|
Available-for-sale investments
|
35
|
|
|
35
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
691
|
|
|
$
|
682
|
|
|
$
|
9
|
|
|
$
|
—
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Short-term
|
|
|
|
|
|
|
|
||||||||
|
Derivative instruments (foreign exchange contracts)
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Long-term
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liability
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
||||
|
Total liabilities measured at fair value
|
$
|
16
|
|
|
$
|
—
|
|
|
$
|
16
|
|
|
$
|
—
|
|
|
|
|
Derivatives in
Cash Flow
Hedging Relationships
|
|
Derivatives
Not
Designated
as Hedging
Instruments
|
|||||||||||
|
|
|
Forward
Contracts
|
|
Option
Contracts
|
|
Forward
Contracts
|
Option
Contracts
|
||||||||
|
Currency
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
|
Buy/(Sell)
|
Buy/(Sell)
|
||||||||
|
|
|
(in millions)
|
|
||||||||||||
|
Euro
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
92
|
|
42
|
|
|
|
British Pound
|
|
—
|
|
|
—
|
|
|
14
|
|
—
|
|
||||
|
Singapore Dollar
|
|
9
|
|
|
—
|
|
|
—
|
|
—
|
|
||||
|
Malaysian Ringgit
|
|
81
|
|
|
—
|
|
|
(5
|
)
|
—
|
|
||||
|
Japanese Yen
|
|
(76
|
)
|
|
—
|
|
|
(29
|
)
|
—
|
|
||||
|
Other
|
|
—
|
|
|
—
|
|
|
7
|
|
—
|
|
||||
|
|
|
$
|
14
|
|
|
$
|
—
|
|
|
$
|
79
|
|
$
|
42
|
|
|
Fair Values of Derivative Instruments
|
||||||||||||||||||
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||||||||||
|
|
|
Fair Value
|
|
|
|
Fair Value
|
||||||||||||
|
Balance Sheet Location
|
|
October 31,
2015 |
|
October 31,
2014 |
|
Balance Sheet Location
|
|
October 31,
2015 |
|
October 31,
2014 |
||||||||
|
(in millions)
|
||||||||||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cash flow hedges
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current assets
|
|
$
|
—
|
|
|
$
|
7
|
|
|
Other accrued liabilities
|
|
$
|
8
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current assets
|
|
1
|
|
|
2
|
|
|
Other accrued liabilities
|
|
2
|
|
|
2
|
|
||||
|
Total derivatives
|
|
$
|
1
|
|
|
$
|
9
|
|
|
|
|
$
|
10
|
|
|
$
|
3
|
|
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
||||||
|
Cash flow hedges
|
|
|
|
|
|
||||||
|
Gain (loss) recognized in accumulated other comprehensive income
|
$
|
(15
|
)
|
|
$
|
5
|
|
|
$
|
—
|
|
|
Gain (loss) reclassified from accumulated other comprehensive income into cost of products
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
||||||
|
Gain (loss) recognized in other income (expense), net
|
$
|
(7
|
)
|
|
$
|
3
|
|
|
$
|
—
|
|
|
|
Workforce reduction
|
U.S. Pre-retirement Plan
|
||||
|
|
(in millions)
|
|||||
|
Balance as of October 31, 2014
|
$
|
1
|
|
$
|
—
|
|
|
Income statement expense
|
8
|
|
8
|
|
||
|
Cash payments
|
(5
|
)
|
(6
|
)
|
||
|
Balance as of October 31, 2015
|
$
|
4
|
|
$
|
2
|
|
|
|
Year ended
|
||||||
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
|
||||||
|
Cost of products and services
|
$
|
4
|
|
|
$
|
(1
|
)
|
|
Research and development
|
2
|
|
|
(1
|
)
|
||
|
Selling, general and administrative
|
10
|
|
|
(1
|
)
|
||
|
Total restructuring and other related costs
|
$
|
16
|
|
|
$
|
(3
|
)
|
|
|
Defined Benefit Plans
|
|
U.S. Post-Retirement Benefit Plan
|
||||||||||||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
|||||||||||||||||||||||||||||||
|
|
2015
|
|
2014
|
|
2013
|
|
2015
|
|
2014
|
|
2013
|
|
2015
|
|
2014
|
|
2013
|
||||||||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||||||||||||||
|
Net periodic benefit cost (benefit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Service cost — benefits earned during the period
|
$
|
22
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
18
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Interest cost on benefit obligation
|
20
|
|
|
5
|
|
|
—
|
|
|
41
|
|
|
11
|
|
|
—
|
|
|
7
|
|
|
2
|
|
|
—
|
|
|||||||||
|
Expected return on plan assets
|
(38
|
)
|
|
(10
|
)
|
|
—
|
|
|
(72
|
)
|
|
(19
|
)
|
|
—
|
|
|
(13
|
)
|
|
(4
|
)
|
|
—
|
|
|||||||||
|
Amortization of net actuarial loss
|
4
|
|
|
1
|
|
|
—
|
|
|
27
|
|
|
7
|
|
|
—
|
|
|
12
|
|
|
2
|
|
|
—
|
|
|||||||||
|
Amortization of prior service credit
|
(7
|
)
|
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(21
|
)
|
|
(5
|
)
|
|
—
|
|
|||||||||
|
Net periodic benefit cost (benefit)
|
1
|
|
|
—
|
|
|
—
|
|
|
13
|
|
|
3
|
|
|
—
|
|
|
(14
|
)
|
|
(5
|
)
|
|
—
|
|
|||||||||
|
Allocated benefit cost (benefit) from Agilent
|
—
|
|
|
3
|
|
|
9
|
|
|
—
|
|
|
9
|
|
|
23
|
|
|
—
|
|
|
(9
|
)
|
|
(10
|
)
|
|||||||||
|
Total periodic benefit cost (benefit)
|
$
|
1
|
|
|
$
|
3
|
|
|
$
|
9
|
|
|
$
|
13
|
|
|
$
|
12
|
|
|
$
|
23
|
|
|
$
|
(14
|
)
|
|
$
|
(14
|
)
|
|
$
|
(10
|
)
|
|
Other changes in plan assets and benefit obligations recognized in other comprehensive (income) loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Prior service credits assumed at the Capitalization
|
$
|
—
|
|
|
$
|
(33
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(102
|
)
|
|
$
|
—
|
|
|
Net actuarial loss assumed at the Capitalization
|
—
|
|
|
40
|
|
|
—
|
|
|
—
|
|
|
367
|
|
|
—
|
|
|
—
|
|
|
75
|
|
|
—
|
|
|||||||||
|
Net actuarial loss
|
57
|
|
|
5
|
|
|
—
|
|
|
51
|
|
|
39
|
|
|
—
|
|
|
31
|
|
|
7
|
|
|
—
|
|
|||||||||
|
Amortization of net actuarial loss
|
(4
|
)
|
|
(1
|
)
|
|
—
|
|
|
(27
|
)
|
|
(7
|
)
|
|
—
|
|
|
(12
|
)
|
|
(2
|
)
|
|
—
|
|
|||||||||
|
Amortization of prior service credit
|
7
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
21
|
|
|
5
|
|
|
—
|
|
|||||||||
|
Foreign currency
|
—
|
|
|
—
|
|
|
—
|
|
|
24
|
|
|
9
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
Total recognized in other comprehensive (income) loss
|
$
|
60
|
|
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
49
|
|
|
$
|
405
|
|
|
$
|
—
|
|
|
$
|
40
|
|
|
$
|
(17
|
)
|
|
$
|
—
|
|
|
Total recognized in net periodic benefit cost (benefit) and other comprehensive (income) loss
|
$
|
61
|
|
|
$
|
15
|
|
|
$
|
9
|
|
|
$
|
62
|
|
|
$
|
417
|
|
|
$
|
23
|
|
|
$
|
26
|
|
|
$
|
(31
|
)
|
|
$
|
(10
|
)
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S.
Post-Retirement
Benefit Plan
|
||||||||||||||||||
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
|
2015
|
|
2014
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
Change in fair value of plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Fair value — beginning of year
|
$
|
491
|
|
|
$
|
—
|
|
|
$
|
1,318
|
|
|
$
|
—
|
|
|
$
|
187
|
|
|
$
|
—
|
|
|
Assets received from Agilent
|
—
|
|
|
490
|
|
|
9
|
|
|
1,358
|
|
|
—
|
|
|
189
|
|
||||||
|
Actual return on plan assets
|
7
|
|
|
7
|
|
|
81
|
|
|
46
|
|
|
2
|
|
|
2
|
|
||||||
|
Employer contributions
|
—
|
|
|
—
|
|
|
48
|
|
|
10
|
|
|
1
|
|
|
—
|
|
||||||
|
Benefits paid
|
(23
|
)
|
|
(6
|
)
|
|
(33
|
)
|
|
(9
|
)
|
|
(11
|
)
|
|
(4
|
)
|
||||||
|
Currency impact
|
—
|
|
|
—
|
|
|
(80
|
)
|
|
(87
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Fair value — end of year
|
$
|
475
|
|
|
$
|
491
|
|
|
$
|
1,343
|
|
|
$
|
1,318
|
|
|
$
|
179
|
|
|
$
|
187
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Benefit obligation — beginning of year
|
$
|
514
|
|
|
$
|
—
|
|
|
$
|
1,429
|
|
|
$
|
—
|
|
|
$
|
206
|
|
|
$
|
—
|
|
|
Liabilities assumed from Agilent
|
—
|
|
|
508
|
|
|
—
|
|
|
1,446
|
|
|
—
|
|
|
203
|
|
||||||
|
Service cost
|
22
|
|
|
5
|
|
|
18
|
|
|
4
|
|
|
1
|
|
|
—
|
|
||||||
|
Interest cost
|
20
|
|
|
5
|
|
|
41
|
|
|
11
|
|
|
7
|
|
|
2
|
|
||||||
|
Plan amendment
|
—
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Actuarial loss
|
27
|
|
|
2
|
|
|
60
|
|
|
70
|
|
|
20
|
|
|
5
|
|
||||||
|
Benefits paid
|
(24
|
)
|
|
(6
|
)
|
|
(33
|
)
|
|
(9
|
)
|
|
(11
|
)
|
|
(4
|
)
|
||||||
|
Currency impact
|
—
|
|
|
—
|
|
|
(90
|
)
|
|
(92
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Benefit obligation — end of year
|
$
|
559
|
|
|
$
|
514
|
|
|
$
|
1,425
|
|
|
$
|
1,429
|
|
|
$
|
223
|
|
|
$
|
206
|
|
|
Underfunded status of PBO
|
$
|
(84
|
)
|
|
$
|
(23
|
)
|
|
$
|
(82
|
)
|
|
$
|
(111
|
)
|
|
$
|
(44
|
)
|
|
$
|
(19
|
)
|
|
Amounts recognized in the consolidated balance sheet consist of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other assets
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
57
|
|
|
$
|
48
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Employee compensation and benefits
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Retirement and post-retirement benefits
|
(83
|
)
|
|
(22
|
)
|
|
(139
|
)
|
|
(159
|
)
|
|
(44
|
)
|
|
(19
|
)
|
||||||
|
Net liability
|
$
|
(84
|
)
|
|
$
|
(23
|
)
|
|
$
|
(82
|
)
|
|
$
|
(111
|
)
|
|
$
|
(44
|
)
|
|
$
|
(19
|
)
|
|
Amounts recognized in accumulated other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Actuarial losses
|
$
|
97
|
|
|
$
|
44
|
|
|
$
|
430
|
|
|
$
|
408
|
|
|
$
|
99
|
|
|
$
|
80
|
|
|
Prior service credits
|
(25
|
)
|
|
(32
|
)
|
|
(4
|
)
|
|
(3
|
)
|
|
(76
|
)
|
|
(97
|
)
|
||||||
|
Total
|
$
|
72
|
|
|
$
|
12
|
|
|
$
|
426
|
|
|
$
|
405
|
|
|
$
|
23
|
|
|
$
|
(17
|
)
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S. Post-Retirement
Benefit Plan
|
||||||
|
|
(in millions)
|
||||||||||
|
Amortization of net prior service credit
|
$
|
(7
|
)
|
|
$
|
(1
|
)
|
|
$
|
(17
|
)
|
|
Amortization of actuarial net loss
|
$
|
9
|
|
|
$
|
27
|
|
|
$
|
20
|
|
|
|
|
|
Fair Value Measurement
at October 31, 2015 Using
|
||||||||||||
|
|
October 31,
2015 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
4
|
|
|
$
|
1
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Equity
|
374
|
|
|
94
|
|
|
280
|
|
|
—
|
|
||||
|
Fixed Income
|
97
|
|
|
21
|
|
|
76
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
475
|
|
|
$
|
116
|
|
|
$
|
359
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement
at October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
6
|
|
|
$
|
1
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
Equity
|
365
|
|
|
86
|
|
|
279
|
|
|
—
|
|
||||
|
Fixed Income
|
120
|
|
|
40
|
|
|
80
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
491
|
|
|
$
|
127
|
|
|
$
|
364
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2015 Using
|
||||||||||||
|
|
October 31,
2015 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
4
|
|
|
$
|
3
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
Equity
|
137
|
|
|
34
|
|
|
103
|
|
|
—
|
|
||||
|
Fixed Income
|
38
|
|
|
8
|
|
|
30
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
179
|
|
|
$
|
45
|
|
|
$
|
134
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
3
|
|
|
$
|
1
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
Equity
|
143
|
|
|
34
|
|
|
109
|
|
|
—
|
|
||||
|
Fixed Income
|
41
|
|
|
14
|
|
|
27
|
|
|
—
|
|
||||
|
Other Investments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
187
|
|
|
$
|
49
|
|
|
$
|
138
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2015 Using
|
||||||||||||
|
|
October 31,
2015 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
7
|
|
|
$
|
2
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
Equity
|
709
|
|
|
129
|
|
|
580
|
|
|
—
|
|
||||
|
Fixed Income
|
624
|
|
|
20
|
|
|
604
|
|
|
—
|
|
||||
|
Other Investments
|
3
|
|
|
—
|
|
|
3
|
|
|
—
|
|
||||
|
Total assets measured at fair value
|
$
|
1,343
|
|
|
$
|
151
|
|
|
$
|
1,192
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at
October 31, 2014 Using
|
||||||||||||
|
|
October 31,
2014 |
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(in millions)
|
||||||||||||||
|
Cash and Cash Equivalents
|
$
|
5
|
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
Equity
|
672
|
|
|
150
|
|
|
522
|
|
|
—
|
|
||||
|
Fixed Income
|
603
|
|
|
23
|
|
|
580
|
|
|
—
|
|
||||
|
Other Investments
|
38
|
|
|
—
|
|
|
21
|
|
|
17
|
|
||||
|
Total assets measured at fair value
|
$
|
1,318
|
|
|
$
|
175
|
|
|
$
|
1,126
|
|
|
$
|
17
|
|
|
|
Year Ended
|
||||||
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Balance, beginning of year
|
$
|
17
|
|
|
$
|
—
|
|
|
Realized gains
|
—
|
|
|
—
|
|
||
|
Unrealized gains/(losses)
|
—
|
|
|
1
|
|
||
|
Purchases, sales, issuances, and settlements
|
(17
|
)
|
|
(5
|
)
|
||
|
Transfers in (out)
|
—
|
|
|
21
|
|
||
|
Balance, end of year
|
$
|
—
|
|
|
$
|
17
|
|
|
|
2015
|
|
2014
|
||||||||||||
|
|
Benefit
Obligation
|
|
Fair Value of Plan Assets
|
|
Benefit
Obligation
|
|
Fair Value of Plan Assets
|
||||||||
|
|
|
||||||||||||||
|
|
PBO
|
|
|
PBO
|
|
||||||||||
|
|
(in millions)
|
|
(in millions)
|
||||||||||||
|
U.S. defined benefit plans where PBO exceeds the fair value of plan assets
|
$
|
559
|
|
|
$
|
475
|
|
|
$
|
514
|
|
|
$
|
491
|
|
|
U.S. defined benefit plans where fair value of plan assets exceeds PBO
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total
|
$
|
559
|
|
|
$
|
475
|
|
|
$
|
514
|
|
|
$
|
491
|
|
|
Non-U.S. defined benefit plans where PBO exceeds or is equal to the fair value of plan assets
|
$
|
1,061
|
|
|
$
|
921
|
|
|
$
|
1,111
|
|
|
$
|
952
|
|
|
Non-U.S. defined benefit plans where fair value of plan assets exceeds PBO
|
364
|
|
|
422
|
|
|
318
|
|
|
366
|
|
||||
|
Total
|
$
|
1,425
|
|
|
$
|
1,343
|
|
|
$
|
1,429
|
|
|
$
|
1,318
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
ABO
|
|
|
|
ABO
|
|
|
||||||||
|
U.S. defined benefit plans where ABO exceeds the fair value of plan assets
|
$
|
527
|
|
|
$
|
475
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
U.S. defined benefit plans where the fair value of plan assets exceeds ABO
|
—
|
|
|
—
|
|
|
472
|
|
|
491
|
|
||||
|
Total
|
$
|
527
|
|
|
$
|
475
|
|
|
$
|
477
|
|
|
$
|
491
|
|
|
Non-U.S. defined benefit plans where ABO exceeds or is equal to the fair value of plan assets
|
$
|
1,031
|
|
|
$
|
921
|
|
|
$
|
1,081
|
|
|
$
|
952
|
|
|
Non-U.S. defined benefit plans where fair value of plan assets exceeds ABO
|
354
|
|
|
422
|
|
|
310
|
|
|
366
|
|
||||
|
Total
|
$
|
1,385
|
|
|
$
|
1,343
|
|
|
$
|
1,391
|
|
|
$
|
1,318
|
|
|
|
U.S. Defined
Benefit Plans
|
|
Non-U.S. Defined
Benefit Plans
|
|
U.S. Post-Retirement
Benefit Plan
|
||||||
|
|
(in millions)
|
||||||||||
|
2016
|
$
|
35
|
|
|
$
|
35
|
|
|
$
|
17
|
|
|
2017
|
$
|
38
|
|
|
$
|
37
|
|
|
$
|
17
|
|
|
2018
|
$
|
39
|
|
|
$
|
40
|
|
|
$
|
18
|
|
|
2019
|
$
|
42
|
|
|
$
|
45
|
|
|
$
|
17
|
|
|
2020
|
$
|
47
|
|
|
$
|
48
|
|
|
$
|
17
|
|
|
2021 - 2025
|
$
|
254
|
|
|
$
|
316
|
|
|
$
|
80
|
|
|
|
For years ended October 31,
|
||
|
|
2015
|
|
2014
|
|
U.S. Defined Benefit Plans:
|
|
|
|
|
Discount rate
|
4.00%
|
|
4.00%
|
|
Average increase in compensation levels
|
3.50%
|
|
3.50%
|
|
Expected long-term return on assets
|
8.00%
|
|
8.00%
|
|
Non-U.S. Defined Benefit Plans:
|
|
|
|
|
Discount rate
|
1.50-4.00%
|
|
1.75-4.25%
|
|
Average increase in compensation levels
|
2.50-3.25%
|
|
2.50-3.25%
|
|
Expected long-term return on assets
|
4.00-6.50%
|
|
4.00-6.50%
|
|
U.S. Post-Retirement Benefits Plan:
|
|
|
|
|
Discount rate
|
3.75%
|
|
4.00%
|
|
Expected long-term return on assets
|
8.00%
|
|
8.00%
|
|
Current medical cost trend rate
|
8.00%
|
|
8.00%
|
|
Ultimate medical cost trend rate
|
3.50%
|
|
3.50%
|
|
Medical cost trend rate decreases to ultimate rate in year
|
2028
|
|
2028
|
|
|
As of the years ended October 31,
|
||
|
|
2015
|
|
2014
|
|
U.S. Defined Benefit Plans:
|
|
|
|
|
Discount rate
|
4.00%
|
|
4.00%
|
|
Average increase in compensation levels
|
3.00%
|
|
3.50%
|
|
Non-U.S. Defined Benefit Plans:
|
|
|
|
|
Discount rate
|
0.76-3.80%
|
|
1.50-4.00%
|
|
Average increase in compensation levels
|
2.50-3.50%
|
|
2.50-3.25%
|
|
U.S. Post-Retirement Benefits Plan:
|
|
|
|
|
Discount rate
|
4.00%
|
|
3.75%
|
|
Current medical cost trend rate
|
7.00%
|
|
8.00%
|
|
Ultimate medical cost trend rate
|
3.50%
|
|
3.50%
|
|
Medical cost trend rate decreases to ultimate rate in year
|
2028
|
|
2028
|
|
|
Years Ended October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Beginning balance
|
$
|
51
|
|
|
$
|
38
|
|
|
Accruals for warranties, including change in estimates
|
33
|
|
|
46
|
|
||
|
Settlements made during the period
|
(31
|
)
|
|
(33
|
)
|
||
|
Ending balance
|
53
|
|
|
$
|
51
|
|
|
|
Accruals for warranties due within one year
|
$
|
34
|
|
|
$
|
34
|
|
|
Accruals for warranties due after one year
|
19
|
|
|
17
|
|
||
|
Ending balance as of October 31
|
$
|
53
|
|
|
$
|
51
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
2019 Senior Notes at 3.30%
|
$
|
499
|
|
|
$
|
499
|
|
|
2024 Senior Notes at 4.55%
|
600
|
|
|
600
|
|
||
|
Total
|
$
|
1,099
|
|
|
$
|
1,099
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Unrealized gain on equity securities, net of tax (expense) of $(6) and $(4)
|
$
|
21
|
|
|
$
|
16
|
|
|
Foreign currency translation, net of tax (expense) of $(63) and $(63)
|
(48
|
)
|
|
6
|
|
||
|
Unrealized losses on defined benefit plans, net of tax benefit of $78 and $42
|
(446
|
)
|
|
(361
|
)
|
||
|
Unrealized gains (losses) on derivative instruments, net of tax benefit (expense) of $3 and $(2)
|
(6
|
)
|
|
3
|
|
||
|
Total accumulated other comprehensive loss
|
$
|
(479
|
)
|
|
$
|
(336
|
)
|
|
|
|
|
|
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
||||||||||||||
|
|
Unrealized gain on equity securities
|
|
Foreign currency translation
|
|
Actuarial Losses
|
|
Prior service credits
|
|
Unrealized gains (losses) on derivatives
|
|
Total
|
||||||||||||
|
|
(in millions)
|
||||||||||||||||||||||
|
As of October 31, 2013 (a)
|
$
|
5
|
|
|
$
|
26
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Pre-Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss) before reclassifications
|
9
|
|
|
(15
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
||||||
|
Tax (expense) benefit
|
(3
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
||||||
|
Other comprehensive income (loss) for nine months period ended July 31, 2014 (b)
|
6
|
|
|
(14
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Assumption of accumulated unrealized translation adjustment, losses on pension and other post-employment benefits
|
—
|
|
|
31
|
|
|
(483
|
)
|
|
139
|
|
|
—
|
|
|
(313
|
)
|
||||||
|
Tax (expense) benefit
|
3
|
|
|
21
|
|
|
77
|
|
|
(51
|
)
|
|
—
|
|
|
50
|
|
||||||
|
Net assumptions (c)
|
3
|
|
|
52
|
|
|
(406
|
)
|
|
88
|
|
|
—
|
|
|
(263
|
)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Post Capitalization
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other comprehensive income (loss) before reclassifications
|
3
|
|
|
(58
|
)
|
|
(60
|
)
|
|
—
|
|
|
5
|
|
|
(110
|
)
|
||||||
|
Amounts reclassified out of accumulated other comprehensive income
|
—
|
|
|
—
|
|
|
9
|
|
|
(8
|
)
|
|
—
|
|
|
1
|
|
||||||
|
Tax (expense) benefit
|
(1
|
)
|
|
—
|
|
|
13
|
|
|
3
|
|
|
(2
|
)
|
|
13
|
|
||||||
|
Other comprehensive income (loss) for three months period ended October 31, 2014 (d)
|
2
|
|
|
(58
|
)
|
|
(38
|
)
|
|
(5
|
)
|
|
3
|
|
|
(96
|
)
|
||||||
|
As of October 31, 2014 (e) = (a+b+c+d)
|
16
|
|
|
6
|
|
|
(444
|
)
|
|
83
|
|
|
3
|
|
|
(336
|
)
|
||||||
|
Other comprehensive income (loss) before reclassifications
|
7
|
|
|
(54
|
)
|
|
(135
|
)
|
|
—
|
|
|
(15
|
)
|
|
(197
|
)
|
||||||
|
Amounts reclassified out of accumulated other comprehensive income
|
—
|
|
|
—
|
|
|
43
|
|
|
(29
|
)
|
|
1
|
|
|
15
|
|
||||||
|
Tax (expense) benefit
|
(2
|
)
|
|
—
|
|
|
25
|
|
|
11
|
|
|
5
|
|
|
39
|
|
||||||
|
Other comprehensive income (loss) for the twelve months ended October 31, 2015 (f)
|
5
|
|
|
(54
|
)
|
|
(67
|
)
|
|
(18
|
)
|
|
(9
|
)
|
|
(143
|
)
|
||||||
|
As of October 31, 2015 (e+f)
|
$
|
21
|
|
|
$
|
(48
|
)
|
|
$
|
(511
|
)
|
|
$
|
65
|
|
|
$
|
(6
|
)
|
|
$
|
(479
|
)
|
|
Details about accumulated other comprehensive loss components
|
Amounts Reclassified from other comprehensive loss
|
|
Affected line item in statement of operations
|
||||||
|
|
Year Ended
|
|
|
||||||
|
|
October 31,
|
|
|
||||||
|
|
2015
|
|
2014
|
|
|
||||
|
|
(in millions)
|
|
|
||||||
|
Unrealized loss on derivatives
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
Cost of products
|
|
|
—
|
|
|
—
|
|
|
Provision for income tax
|
||
|
|
(1
|
)
|
|
—
|
|
|
Net of Income Tax
|
||
|
|
|
|
|
|
|
||||
|
Net defined benefit pension cost and post retirement plan costs:
|
|
|
|
|
|
||||
|
Actuarial net loss
|
(43
|
)
|
|
(9
|
)
|
|
|
||
|
Prior service benefit
|
29
|
|
|
8
|
|
|
|
||
|
|
(14
|
)
|
|
(1
|
)
|
|
Total before income tax
|
||
|
|
5
|
|
|
—
|
|
|
Provision for income tax
|
||
|
|
(9
|
)
|
|
(1
|
)
|
|
Net of income tax
|
||
|
|
|
|
|
|
|
||||
|
Total reclassifications for the period
|
$
|
(10
|
)
|
|
$
|
(1
|
)
|
|
|
|
|
Measurement Solutions
|
|
Customer Support and Services
|
|
Total
Segments
|
||||||
|
|
(in millions)
|
||||||||||
|
Year ended October 31, 2015:
|
|
|
|
|
|
||||||
|
Total segment revenue
|
$
|
2,461
|
|
|
$
|
401
|
|
|
$
|
2,862
|
|
|
Acquisition related fair value adjustments
|
(6
|
)
|
|
—
|
|
|
(6
|
)
|
|||
|
Total net revenue
|
$
|
2,455
|
|
|
$
|
401
|
|
|
$
|
2,856
|
|
|
Income from operations
|
$
|
487
|
|
|
$
|
72
|
|
|
$
|
559
|
|
|
Depreciation expense
|
$
|
68
|
|
|
$
|
13
|
|
|
$
|
81
|
|
|
Year ended October 31, 2014:
|
|
|
|
|
|
||||||
|
Total net revenue
|
$
|
2,533
|
|
|
$
|
400
|
|
|
$
|
2,933
|
|
|
Income from operations
|
$
|
508
|
|
|
$
|
93
|
|
|
$
|
601
|
|
|
Depreciation expense
|
$
|
64
|
|
|
$
|
10
|
|
|
$
|
74
|
|
|
Year ended October 31, 2013:
|
|
|
|
|
|
||||||
|
Total net revenue
|
$
|
2,493
|
|
|
395
|
|
|
$
|
2,888
|
|
|
|
Income from operations
|
$
|
484
|
|
|
$
|
99
|
|
|
$
|
583
|
|
|
Depreciation expense
|
$
|
56
|
|
|
$
|
9
|
|
|
$
|
65
|
|
|
|
Years Ended October 31,
|
||||||||||
|
|
2015
|
|
2014
|
|
2013
|
||||||
|
|
(in millions)
|
||||||||||
|
Total reportable segments' income from operations
|
$
|
559
|
|
|
$
|
601
|
|
|
$
|
583
|
|
|
Restructuring related costs
|
(14
|
)
|
|
3
|
|
|
(15
|
)
|
|||
|
Asset impairments
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
|||
|
Transformational programs
|
—
|
|
|
(1
|
)
|
|
(4
|
)
|
|||
|
Amortization of intangibles
|
(14
|
)
|
|
(8
|
)
|
|
(9
|
)
|
|||
|
Acquisition and integration costs
|
(16
|
)
|
|
(1
|
)
|
|
(8
|
)
|
|||
|
Share-based compensation expense
|
(55
|
)
|
|
(44
|
)
|
|
(43
|
)
|
|||
|
Acquisition related fair value adjustments
|
(9
|
)
|
|
—
|
|
|
—
|
|
|||
|
Separation and related costs
|
(20
|
)
|
|
(78
|
)
|
|
(2
|
)
|
|||
|
Other
|
1
|
|
|
(3
|
)
|
|
(5
|
)
|
|||
|
Interest Income
|
1
|
|
|
—
|
|
|
—
|
|
|||
|
Interest expense
|
(46
|
)
|
|
(3
|
)
|
|
—
|
|
|||
|
Other income (expense), net
|
2
|
|
|
9
|
|
|
5
|
|
|||
|
Income before taxes, as reported
|
$
|
388
|
|
|
$
|
475
|
|
|
$
|
501
|
|
|
|
Measurement Solutions
|
|
Customer Support & Services
|
|
Total
Segments
|
||||||
|
|
(in millions)
|
||||||||||
|
As of October 31, 2015:
|
|
|
|
|
|
||||||
|
Assets
|
$
|
2,531
|
|
|
$
|
265
|
|
|
$
|
2,796
|
|
|
Capital expenditures
|
$
|
77
|
|
|
$
|
15
|
|
|
$
|
92
|
|
|
As of October 31, 2014:
|
|
|
|
|
|
||||||
|
Assets
|
$
|
1,740
|
|
|
$
|
236
|
|
|
$
|
1,976
|
|
|
Capital expenditures
|
$
|
60
|
|
|
$
|
10
|
|
|
$
|
70
|
|
|
|
October 31,
|
||||||
|
|
2015
|
|
2014
|
||||
|
|
(in millions)
|
||||||
|
Total reportable segments' assets
|
$
|
2,796
|
|
|
$
|
1,976
|
|
|
Cash, cash equivalents and short-term investments
|
483
|
|
|
810
|
|
||
|
Prepaid expenses
|
98
|
|
|
51
|
|
||
|
Other current assets
|
2
|
|
|
9
|
|
||
|
Investments
|
70
|
|
|
63
|
|
||
|
Long-term and other receivables
|
57
|
|
|
33
|
|
||
|
Other
|
2
|
|
|
108
|
|
||
|
Total assets
|
$
|
3,508
|
|
|
$
|
3,050
|
|
|
|
United
States
|
|
China
|
|
Japan
|
|
Rest of the
World
|
|
Total
|
||||||||||
|
|
(in millions)
|
||||||||||||||||||
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Year ended October 31, 2015
|
$
|
991
|
|
|
$
|
531
|
|
|
$
|
311
|
|
|
$
|
1,023
|
|
|
$
|
2,856
|
|
|
Year ended October 31, 2014
|
$
|
945
|
|
|
$
|
548
|
|
|
$
|
331
|
|
|
$
|
1,109
|
|
|
$
|
2,933
|
|
|
Year ended October 31, 2013
|
$
|
966
|
|
|
$
|
512
|
|
|
$
|
364
|
|
|
$
|
1,046
|
|
|
$
|
2,888
|
|
|
|
United
States
|
|
Japan
|
|
Malaysia
|
|
Rest of the
World
|
|
Total
|
||||||||||
|
|
(in millions)
|
||||||||||||||||||
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
October 31, 2015
|
$
|
251
|
|
|
$
|
144
|
|
|
$
|
80
|
|
|
$
|
191
|
|
|
$
|
666
|
|
|
October 31, 2014
|
$
|
218
|
|
|
$
|
157
|
|
|
$
|
86
|
|
|
$
|
142
|
|
|
$
|
603
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
January 31,
|
|
April 30,
|
|
July 31,
|
|
October 31,
|
||||||||
|
|
(in millions, except per share data)
|
||||||||||||||
|
2015
|
|
|
|
|
|
|
|
||||||||
|
Net revenue
|
$
|
701
|
|
|
$
|
740
|
|
|
$
|
665
|
|
|
$
|
750
|
|
|
Gross profit
|
383
|
|
|
416
|
|
|
370
|
|
|
418
|
|
||||
|
Income from operations
(a)
|
87
|
|
|
133
|
|
|
100
|
|
|
111
|
|
||||
|
Net income
|
$
|
70
|
|
|
$
|
96
|
|
|
$
|
70
|
|
|
$
|
277
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.42
|
|
|
$
|
0.57
|
|
|
$
|
0.41
|
|
|
$
|
1.63
|
|
|
Diluted
|
$
|
0.41
|
|
|
$
|
0.56
|
|
|
$
|
0.41
|
|
|
$
|
1.61
|
|
|
Weighted average shares used in computing net income per
share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
168
|
|
|
169
|
|
|
169
|
|
|
170
|
|
||||
|
Diluted
|
170
|
|
|
171
|
|
|
172
|
|
|
172
|
|
||||
|
Range of stock prices on NYSE
|
28.56 - 36.33
|
|
33.37 - 38.99
|
|
29.51 - 36.31
|
|
29.28 - 34.13
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
2014
|
|
|
|
|
|
|
|
||||||||
|
Net revenue
|
$
|
671
|
|
|
$
|
743
|
|
|
$
|
757
|
|
|
$
|
762
|
|
|
Gross profit
|
372
|
|
|
415
|
|
|
414
|
|
|
419
|
|
||||
|
Income from operations
|
91
|
|
|
127
|
|
|
121
|
|
|
130
|
|
||||
|
Net income
|
$
|
74
|
|
|
$
|
110
|
|
|
$
|
107
|
|
|
$
|
101
|
|
|
Net income per share - basic and diluted
(b)
|
$
|
0.44
|
|
|
$
|
0.66
|
|
|
$
|
0.64
|
|
|
$
|
0.60
|
|
|
Basic and diluted average shares outstanding
(b)
|
167
|
|
|
167
|
|
|
167
|
|
|
167
|
|
||||
|
Plan Category
|
Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights
|
|
Weighted-average Exercise Price of Outstanding Options, Warrants and Rights
|
|
Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
|
||||
|
|
(a)
|
|
(b)
|
|
(c)
|
||||
|
Equity compensation plans approved by security holders (1)(2)(3)
|
7,146,587
|
|
|
$
|
24
|
|
|
32,472,436
|
|
|
Equity compensation plans not approved by security holders
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
Total
|
7,146,587
|
|
|
$
|
24
|
|
|
32,472,436
|
|
|
(1)
|
The number of securities remaining available for future issuance in column (c) includes 24,506,711 shares of common stock authorized and available for issuance under the Keysight Technologies, Inc. Employee Stock Purchase Plan ("423(b) Plan"). The number of shares authorized for issuance under the 423(b) Plan is subject to an automatic annual increase of the lesser of one percent of the outstanding common stock of Keysight or an amount determined by the Compensation Committee of our Board of Directors. Under the terms of the 423(b) Plan, in no event shall the aggregate number of shares issued under the Plan exceed 75 million shares. The number of securities remaining available for future issuance in column (c) is before the issuance of shares of common stock to participants in consideration of the aggregate participant contribution under 423(b) plan totaling $15 million as of October 31, 2015.
|
|
(2)
|
We issue securities under our equity compensation plans in forms other than options, warrants or rights. Those are issued under the 2014 Equity and Incentive Compensation Plan which was originally adopted by the Board on July 16, 2014, subsequently amended and restated by the Board on September 29, 2014 and January 22, 2015 and became effective as of November 1, 2014 (the “Effective Date”). The 2014 Plan provides for the grant of awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and performance units with performance-based conditions to vesting or exercisability, and cash awards. The 2014 Plan has a term of ten years.
|
|
(3)
|
We issue securities under our equity compensation plans in forms which do not require a payment by the recipient to us at the time of exercise or vesting, including restricted stock, restricted stock units and performance units. Accordingly, the weighted-average exercise price in column (b) does not take these awards into account.
|
|
(a)
|
The following documents are filed as part of this report:
|
|
1.
|
Financial Statements.
|
|
2.
|
Financial Statement Schedule.
|
|
Description
|
|
Balance at
Beginning of Period |
|
Additions Charged to
Expenses or Other Accounts* |
|
Deductions Credited to Expenses or Other Accounts**
|
|
Balance at
End of Period |
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
2015
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
39
|
|
|
$
|
43
|
|
|
$
|
(36
|
)
|
|
$
|
46
|
|
|
2014
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
41
|
|
|
$
|
4
|
|
|
$
|
(6
|
)
|
|
$
|
39
|
|
|
2013
|
|
|
|
|
|
|
|
|
||||||||
|
Tax valuation allowance
|
|
$
|
41
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
41
|
|
|
3.
|
Exhibits.
|
|
|
|
|
|
Incorporation by Reference
|
|||||||
|
Exhibit
Number
|
|
Description
|
|
Form
|
|
Date
|
|
Exhibit
Number
|
|
Filed
Herewith
|
|
|
2.1
|
|
|
Separation and Distribution Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.**
|
|
10-12B/A
|
|
8/13/2014
|
|
2.1
|
|
|
|
2.2
|
|
|
Rule 2.7 Announcement, Recommended Cash Acquisition of Anite Plc by Keysight Technologies B.V. dated June 17, 2015
|
|
8-K
|
|
6/17/2015
|
|
2.1
|
|
|
|
3.1
|
|
|
Amended and Restated Certificate of Incorporation of Keysight Technologies, Inc.
|
|
8-K
|
|
11/3/2014
|
|
3.1
|
|
|
|
3.2
|
|
|
Amended and Restated Bylaws of Keysight Technologies, Inc.
|
|
8-K
|
|
11/3/2014
|
|
3.2
|
|
|
|
4.1
|
|
|
Indenture, dated as of October 15, 2014, between Keysight Technologies, Inc. and U.S. Bank National Association, as Trustee
|
|
8-K
|
|
10/17/2014
|
|
4.1
|
|
|
|
4.2
|
|
|
First Supplemental Indenture, dated as of October 15, 2014, to the Indenture dated as of October 15, 2014, between Keysight Technologies, Inc. and U.S. Bank National Association, as Trustee
|
|
8-K
|
|
10/17/2014
|
|
4.2
|
|
|
|
4.3
|
|
|
Guarantee, dated as of October 15, 2014, by Agilent Technologies, Inc. in favor of U.S. Bank National Association as Trustee for the Holders of Notes specified therein of Keysight Technologies, Inc.
|
|
8-K
|
|
10/17/2014
|
|
4.3
|
|
|
|
4.4
|
|
|
Registration Rights Agreement, dated as of October 15, 2014, by and among Keysight Technologies, Inc., Agilent Technologies, Inc., and Citigroup Global Markets Inc., Goldman, Sachs & Co., and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives of the Initial Purchasers
|
|
8-K
|
|
10/17/2014
|
|
4.4
|
|
|
|
10.1
|
|
|
Services Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.1
|
|
|
|
10.2
|
|
|
Tax Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.2
|
|
|
|
10.3
|
|
|
Employee Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.3
|
|
|
|
10.4
|
|
|
Intellectual Property Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.4
|
|
|
|
10.5
|
|
|
Trademark License Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.5
|
|
|
|
10.6
|
|
|
Real Estate Matters Agreement, dated August 1, 2014, by and between Agilent Technologies, Inc. and Keysight Technologies, Inc.
|
|
10-12B/A
|
|
8/13/2014
|
|
10.6
|
|
|
|
10.7
|
|
|
Form of Indemnification Agreement
|
|
10-12B/A
|
|
7/18/2014
|
|
10.7
|
|
|
|
10.8
|
|
|
Keysight Technologies, Inc. Employee Stock Purchase Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.8
|
|
|
|
10.9
|
|
|
Keysight Technologies, Inc. 2014 Equity and Incentive Compensation Plan (As Amended and Restated on September 29, 2014)*
|
|
S-8
|
|
10/21/2014
|
|
4.3
|
|
|
|
10.10
|
|
|
Form of Keysight Technologies, Inc. Global Stock Award Agreement (with deferral alternative)*
|
|
8-K
|
|
11/3/2014
|
|
10.2
|
|
|
|
10.11
|
|
|
Form of Keysight Technologies, Inc. Global Performance Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.11
|
|
|
|
10.12
|
|
|
Form of Keysight Technologies, Inc. Global Stock Option Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.12
|
|
|
|
10.13
|
|
|
Form of Keysight Technologies, Inc. Non-Employee Director Stock Option Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.13
|
|
|
|
10.14
|
|
|
Form of Keysight Technologies, Inc. Non-Employee Director Stock Award Agreement*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.14
|
|
|
|
10.15
|
|
|
Form of Keysight Technologies, Inc. 2014 Deferred Compensation Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.15
|
|
|
|
10.16
|
|
|
Form of Keysight Technologies, Inc. 2014 Frozen Deferred Compensation Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.16
|
|
|
|
10.17
|
|
|
Form of Keysight Technologies, Inc. Excess Benefit Retirement Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.17
|
|
|
|
10.18
|
|
|
Form of Keysight Technologies, Inc. Supplemental Benefit Retirement Plan*
|
|
10-12B/A
|
|
7/18/2014
|
|
10.18
|
|
|
|
10.19
|
|
|
Agilent Technologies, Inc. France Pension Plan*
|
|
10-12B/A
|
|
8/13/2014
|
|
10.19
|
|
|
|
10.20
|
|
|
Form of Change of Control Severance Agreement*
|
|
8-K
|
|
11/3/2014
|
|
10.1
|
|
|
|
10.21
|
|
|
Credit Agreement, dated September 15, 2014, between Keysight Technologies, Inc., Agilent Technologies, Inc. and the Lenders Party Thereto*
|
|
10-12B/A
|
|
9/22/2014
|
|
10.21
|
|
|
|
10.22
|
|
|
Form of Keysight Technologies, Inc. Deferral Election for Stock Award*
|
|
8-K
|
|
11/3/2014
|
|
10.3
|
|
|
|
10.23
|
|
|
Keysight Technologies, Inc. Officer and Executive Severance Plan (Established Effective March18, 2015)*
|
|
8-K
|
|
3/24/2015
|
|
10.1
|
|
|
|
10.24
|
|
|
Keysight Technologies, Inc. 2014 Equity and Incentive Compensation Plan (As Amended and Restated on January 22, 2015)*
|
|
8-K
|
|
3/24/2015
|
|
10.2
|
|
|
|
10.25
|
|
|
Letter Agreement, dated July 21, 2015, by and among Keysight Technologies, Inc., the Lenders party thereto and Citibank, N.A., as Administrative Agent
|
|
8-K
|
|
7/21/2015
|
|
10.2
|
|
|
|
10.26
|
|
|
Keysight Technologies, Inc. 2015 Performance-based Compensation Plan for covered employees (As Adopted on September 29, 2014)*
|
|
DEF 14A
|
|
2/6/2014
|
|
APPENDIX B
|
|
|
|
10.27
|
|
|
Keysight Technologies, Inc. 401(k) Plan (Effective as of August 1, 2014)*
|
|
|
|
|
|
|
|
X
|
|
10.28
|
|
|
Keysight Technologies, Inc. Deferred Profit-Sharing Plan (Effective as of August 1, 2014)*
|
|
|
|
|
|
|
|
X
|
|
10.29
|
|
|
Keysight Technologies, Inc. Retirement Plan (Effective as of August 1, 2014)*
|
|
|
|
|
|
|
|
X
|
|
10.30
|
|
|
First Amendment to the Keysight Technologies, Inc. 401(k) Plan (Effective as of August 1, 2015)*
|
|
|
|
|
|
|
|
X
|
|
10.31
|
|
|
First Amendment to the Keysight Technologies, Inc. Retirement Plan (Effective as of August 1, 2015)*
|
|
|
|
|
|
|
|
X
|
|
11.1
|
|
|
See Note 7, “Net Income Per Share,” to our Combined and Consolidated Financial Statements.
|
|
|
|
|
|
|
|
X
|
|
12.1
|
|
|
Computation of ratio of earnings to fixed charges.
|
|
|
|
|
|
|
|
X
|
|
14.1
|
|
|
See Investor Information in Item 1: Business of this Annual Report on Form 10-K.
|
|
|
|
|
|
|
|
X
|
|
21.1
|
|
|
Subsidiaries of Keysight Technologies, Inc.
|
|
|
|
|
|
|
|
X
|
|
23.1
|
|
|
Consent of Independent Registered Public Accounting Firm.
|
|
|
|
|
|
|
|
X
|
|
24.1
|
|
|
Powers of Attorney. Contained in the signature page of this Annual Report on Form 10-K.
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
32.2
|
|
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
|
|
|
|
|
|
|
|
X
|
|
99.1
|
|
|
Information Statement of Keysight Technologies, Inc., dated October 8, 2014.
|
|
8-K
|
|
11/3/2014
|
|
99.1
|
|
|
|
99.2
|
|
|
Press release relating to the Offer to Anite Plc.
|
|
8-K
|
|
6/17/2015
|
|
2.1
|
|
|
|
*
|
Indicates management contract or compensatory plan, contract or arrangement.
|
|
**
|
Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Keysight will furnish supplemental copies of any such schedules or exhibits to the U.S. Securities and Exchange Commission upon request.
|
|
|
|
KEYSIGHT TECHNOLOGIES, INC.
|
||
|
|
|
|
|
|
|
|
|
BY
|
|
/s/ Stephen D. Williams
|
|
|
|
|
|
Stephen D. Williams
|
|
|
|
|
|
Senior Vice President, General Counsel and Secretary
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ RONALD S. NERSESIAN
|
|
Director, President and Chief Executive Officer
|
|
December 21, 2015
|
|
Ronald S. Nersesian
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ NEIL DOUGHERTY
|
|
Senior Vice President and Chief Financial Officer
|
|
December 21, 2015
|
|
Neil Dougherty
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
|
|
/s/ JOHN C. SKINNER
|
|
Vice President and Corporate Controller
|
|
December 21, 2015
|
|
John C. Skinner
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ PAUL N. CLARK
|
|
Chairman of the Board
|
|
December 21, 2015
|
|
Paul N. Clark
|
|
|
|
|
|
|
|
|
|
|
|
/s/ JAMES G. CULLEN
|
|
Director
|
|
December 21, 2015
|
|
James G. Cullen
|
|
|
|
|
|
|
|
|
|
|
|
/s/ CHARLES J. DOCKENDORFF
|
|
Director
|
|
December 21, 2015
|
|
Charles J. Dockendorff
|
|
|
|
|
|
|
|
|
|
|
|
/s/ JEAN M. HALLORAN
|
|
Director
|
|
December 21, 2015
|
|
Jean M. Halloran
|
|
|
|
|
|
|
|
|
|
|
|
/s/ RICHARD HAMADA
|
|
Director
|
|
December 21, 2015
|
|
Richard Hamada
|
|
|
|
|
|
|
|
|
|
|
|
/s/ ROBERT A. RANGO
|
|
Director
|
|
December 17, 2015
|
|
Robert A. Rango
|
|
|
|
|
|
|
|
|
|
|
|
/s/ MARK B. TEMPLETON
|
|
Director
|
|
December 21, 2015
|
|
Mark B. Templeton
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|